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The far-ultraviolet circular dichroism spectra of fibrinogens phosphorylated by protein kinase C or casein kinase II indicated a conformational 
change corresponding to an increase in ordered secondary structure. The spectra of protein kinase A- or casein kinase I-phosphorylated fibrinogens 
did not differ substantially from the control. Fluorescence studies indicated changes in the tertiary structure around tryptophan residues for protein 
kinase A- or C-phosphorylated fibrinogens, but failed to show any such change for fibrinogen phosphorylated by either of the casein kinases. This 
latter result was also confirmed by circular dichroism measurements in the near-ultraviolet region. The apparent increase in ordered structure was 
proposed as an explanation for the slower rate of plasmin degradation seen in fibrinogens after phosphorylation by protein kinase C [a], and casein 
kinase II, especially as both spectral changes and plasmin degradation rate were unaffected by alkaline phosphatase. 
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1. INTRODUCTION 
Fibrinogen is a plasma phosphoprotein of molecular 
mass 340 000 which is made up of six polypeptide chains 
(AcuzBpZy~) joined by disulphide bonds. It is known 
that the phosphate content is increased in foetal 
fibrinogen [l] and after major surgery [2] and that in 
vitro phosphorylation by protein kinase C causes a 
decrease in the fibrin fibre thickness in thrombin gela- 
tion assays, which is partially reversed by dephos- 
phorylation [3-51. Moreover, phosphorylation leads to 
a decreased rate of fibrinogen degradation by plasmin 
[6] and (Martin, S.C., Forsberg, P.-O. and Eriksson, 
S.D., unpublished data). Since protein phosphorylation 
may thus have a physiological function in regulating the 
properties of fibrinogen, it is of interest to investigate 
whether phosphorylation of fibrinogen induces any 
measurable conformational changes in the molecule 
and if these changes can be related to the functional 
behaviour of fibrinogen. 
and protein kinase C was purified basically according to [8] with 
modifications [9]. The casein kinases were both prepared as in [lo]. 
The conditions used for the phosphorylation reactions were basically 
as described elsewhere [5,11], except hat the pH was increased to 8.5 
in the protein kinase A reaction to improve the incorporation. After 
the phosphorylation, the incorporation of phosphate was determined 
according to [12] and found to be 1.2, 1.25, 3.5 and 4.15 mol 
phosphate per mol fibrinogen for casein kinase I, casein kinase II, 
protein kinase C and protein kinase A, respectively. The Bbrinogens 
were chromatographed on a Sephacryl S-300 column to remove the 
kinases, lyophilised, redissolved in distilled water, dialysed against 30 
mM potassium phosphate buffer (pH7.4), containing 150 mM NaCl 
and stored at -70°C until use. The control fibrinogen was also 
chromatographed prior to dialysis and storage. 
2.2. Dephosphorylations 
Calf intestinal alkaline phosphatase (Boehringer, Mannheim) was 
dialysed against 25 mM Tris-HCI buffer (pH 7.4); 125 mM NaCl, and 
150 units were used to dephosphorylate 1 mg of the control and 
phosphorylated fibrinogens. Under the conditions used, approx- 
imately half the phosphate was removed from protein kinase A- 
phosphorylated fibrinogen, 75070 from protein kinase C-phos- 
phorylated fibrinogen and 95% from the casein kinase I- or II- 
phosphorylated fibrinogens. 
2.3. Spectroscopic methods 
2. EXPERIMENTAL 
2.1. Phosphorylations 
Human fibrinogen (F-3879) was obtained from Sigma Chemical 
(St. Louis, MO, USA) and prepared for use as in [3] before being 
phosphorylated by protein kinase A, protein kinase C, casein kinase 
I or casein kinase II. Protein kinase A was purified according to [7], 
Circular dichroism (CD) was measured at 22*2”C with a Jasco 
J-41A spectropolarimeter (Japan Spectroscopic, Tokyo, Japan). 
Measurements in the far-UV (200-250 nm) region utilised cells with 
0.1 cm pathlengths and fibrinogen concentrations of 0.12 mg/ml(O.4 
PM). Cells with 1 cm pathlengths and fibrinogen concentrations of 0.7 
mg/ml(2.1 PM) were used for measurements in the near-UV (250-320 
nm) region. The bandwidth was 2 nm in both wavelength regions. The 
fibrinogens were dissolved in 30 mM potassium phosphate buffer (pH 
7.4) containing 150 mM NaCl. 
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4800s spectrofluorimeter (SLM-Aminco, Urbana, IL, USA) with 
fibrinogen concentrations of 0.12 mg/ml (0.4 PM). The excitation 
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Fig. 1. Far-ultraviolet circular dichroism spectra of control and 
phosphorylated fibrinogens. Control fibrinogen (-), mean of 
seven experiments with SEM given at selected wavelengths; protein 
kinase A-phosphorylated fibrinogen (* * - - -), mean of two ex- 
periments with range given at selected wavelengths; protein kinase C- 
phosphorylated fibrinogen (---), mean of four experiments with 
SEM given at selected wavelengths; casein kinase I-phosphorylated 
fibrinogen (-----), mean of two experiments with range given at 
selected wavelengths; casein kinase II-phosphorylated fibrinogen 
(- -), mean of two experiments with range given at selected 
wavelengths. The mean residue ellipticity (deg. cm*. dmol-‘) was 
calculated using a mean residue weight of 113 [16]. 
wavelength was 280 nm and the emission spectrum was measured be 
tween 300 and 400 nm. The excitation and emission bandwidths were 
set at 2 and 4 nm, respectively. 
Fibrinogen concentrations were measured as in [13]. 
3. RESULTS 4. DISCUSSION 
3.1. Far-ultraviolet circular dichroism 
The far-UV CD spectra of the phosphorylated and 
control fibrinogens all showed two minima at 208 nm 
and 220 nm (Fig. l), in agreement with [14,15]. An in- 
crease in negative ellipticity of approx. 10% was 
observed for the fibrinogens phosphorylated by protein 
kinase C or casein kinase II. In contrast, phosphoryla- 
tion by casein kinase I or protein kinase A resulted in 
negligible changes in ellipticity. 
3.2. Near-ultraviolet fluorescence emission and 
In vitro phosphorylation of fibrinogen by protein 
kinase C or casein kinase II resulted in a significant in- 
crease in the negative mean residue ellipticity in the far- 
UV region, indicating a change in the secondary struc- 
ture of fibrinogen that may involve an increase in LY- 
helix content [ 17,181. However, phosphorylation by 
protein kinase A or casein kinase I resulted in negligible 
differences from the control, consistent with the 
phosphate groups added by these enzymes having no 
appreciable effect on the secondary structure of 
fibrinogen. 
circular dichroism 
The fluorescence spectra for the various fibrinogens 
all showed emission maxima at 342 nm (Fig. 2). Protein 
kinase A phosphorylation gave a 10% decrease in 
fluorescence, while protein kinase C phosphorylation 
resulted in a 20% fluorescence increase. However, 
phosphorylation by either casein kinase I or II did not 
affect the fluorescence spectra. The latter results were 
confirmed by near-UV CD studies which showed no 
differences between control and casein kinase I- or II- 
phosphorylated fibrinogens. 
Distinct fluorescence changes were seen after the 
phosphorylation of fibrinogen by protein kinase A or 
protein kinase C, while phosphorylation by either of the 
casein kinases did not alter the fluorescence. These lat- 
ter results were confirmed by similar CD spectra in the 
near-UV region, where the aromatic amino acid 
residues contribute, for fibrinogens phosphorylated by 
the two casein kinases. 
3.3. Effects of dephosphorylation 
When the far-UV CD measurements of control and 
phosphorylated fibrinogens were repeated after treat- 
ment with alkaline phoshatase or buffer, no reversibili- 
Together, these results indicate that phosphorylation 
of fibrinogen by protein kinase C results in a conforma- 
tional change that affects both the secondary structure 
of the protein and the environment around tryptophan 
residues. In contrast, the conformational change ac- 
companying the phosphorylation by casein kinase II ap- 
parently mainly involves fibrinogen’s secondary struc- 
ture without appreciably altering the tryptophan en- 
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Fig. 2. Fluorescence mission spectra of control and phosphorylated 
fibrinogens. Symbols as for Fig. 1. All spectra were normalised to a 
fluorescence intensity for control fibrinogen of 1 .O at the wavelength 
of the emission maximum. For clarity, the spectrum of casein kinase 
I-phosphorylated fibrinogen has been excluded, as it did not differ 
from either the control spectrum or the spectrum of casein kinase II- 
phosphorylated fibrinogen. 
ty of the effects of the protein-bound phosphate was 
seen. The mean residue ellipticities for the dephos- 
phorylated fibrinogens thus varied by less than 3% 
from the values for the buffer-treated fibrinogens, and 
none of the values were significantly different from 
those shown in Fig. 1. 
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vironment . Moreover, phosphorylation by protein 
kinase A seems to result in only local perturbations of 
fibrinogen’s conformation affecting one or more tryp- 
tophan residues, but having no appreciable effect on 
the overall secondary structure. Only phosphorylation 
by casein kinase I does not lead to a detectable ffect on 
fibrinogen conformation. 
The finding that dephosphorylation did not alter the 
far-UV CD spectra cannot simply be atrributed to in- 
complete dephosphorylation, as almost all of the 32P- 
labelled phosphate was removed from the casein kinase- 
phosphorylated fibrinogens. Analogous non-reversi- 
bility has been shown for the inhibition of plasmin 
digestion after the in vitro phosphorylation of fibri- 
nogen ([6] and Martin, S.C., Forsberg, P.-O. and 
Eriksson, S.D., unpublished data). In contrast, the ef- 
fects of fibrinogen phosphorylation on thrombin gela- 
tion assays have been shown to be partially reversible 
[5], with large increases in fibrin fibre thickness after 
the removal of the endogenous phosphate and a smaller 
increase in the thickness of the fibrin fibres from pro- 
tein kinase C-phosphorylated fibrinogen which had 
been thinner than those of the control. 
It has been proposed that plasmin initially attacks the 
a-chains from the carboxy-terminal ends in a region of 
disordered structure [19]. Our results suggesting that 
phosphorylation by two of the four kinases leads to an 
increase in the ordered structure of fibrinogen are thus 
consistent with the idea that the action of plasmin is 
retarded by an increase in the ordered structure in this 
region of fibrinogen [ 151. This appears reasonable since 
both protein kinase C and casein kinase II phosphory- 
late sites in the a-chain towards the carboxy-terminus 
[3,4], and those regions also appear to be phosphory- 
lated by the other two kinases (Martin, S.C., Forsberg, 
P.-O. and Eriksson, SD., unpublished data). 
The non-reversability of the spectral and plasmin 
digestion changes suggest hat the non-covalent bonds 
formed after phosphorylation in this new region of 
ordered structure continue to stabilise the region even 
after dephosphorylation has removed the phosphate 
group(s) which caused the initial conformation change. 
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